Novel 4-Arylpolyhydroquinoline Derivatives: Synthesis and Inhibition of Human Cervical Cancer Cells

Yi-Dong Xie,Qing-Quan Shi,Shang-Wei Li
2018-01-01
Latin american journal of pharmacy
Abstract:A series of 4-arylpolyhydroquinoline derivatives (1-6) were synthesized with the aim of using them as anticancer drugs in clinical trials, and their structures were characterized by IR, 1H NMR, HRMS, and single crystal X-ray crystallography. The anticancer activity of these compounds was investigated against three human cervical cancer cell lines (HeLa, C33a and U14) by MTT assay. The results reveal that compared with compounds 4-6, compounds 1-3 exhibit more potent anticancer activity, which is even better that of the reference drug.
What problem does this paper attempt to address?